Southern blotting is a molecular biology technique for identifying specific DNA in a large DNA sample, separating the desired DNA for DNA assembly, and detecting mutations, deletions, and gene displacement. Phylogenetic analysis, HIV-1 and infectious disease detection, restriction fragment length polymorphism (RFLP), cancer prognosis, and prenatal diagnosis of genetic diseases all employ this technique. This method can also be used in DNA fingerprinting tests like paternity and maternity tests.
The southern blotting market can be divided into four categories: application, product,end-user, and geography. Medical diagnosis, genetic fingerprinting, scientific research, agricultural, and sex determination are the applications that the market is divided into. The market is divided into consumables and instruments based on the type of product. The southern blotting market is divided into biotechnology and pharmaceutical enterprises, research institutes, contract research organizations, and forensic labs based on end-user.
Southern blotting is sold in four regions throughout the world: North America, Asia-Pacific, Europe, and the rest of the world. Because of the discovery of advanced drugs and increased research development, North America is expected to lead the worldwide market, with the United States as a major contributor. Due to increased investment in innovative drug research techniques and a large patient base suffering from chronic diseases, Asia Pacific is expected to rise at a significant rate. Because of the high prevalence of sickness and the aging population in Europe, the market is rapidly expanding.
Key players operating in the global Southern blotting market include AppliedBiosystems, Cleaver Scientific Ltd., Allegan, Agilent technologies, and Cleaver Scientific Ltd.
Read more @ https://cmilatestinsights.blogspot.com/2021/10/global-southern-blotting-market.html
